• Home
  • About Journal
    Journal Introduction
    Editorial Board
    Youth Editorial Board
    Cooperating Institutions
    Editorial Department
  • Submission Guidelines
  • Policies & Statements
    Ethical Guidelines for Publication
    Academic Misconduct Statement
    Open Access (OA) Statement
    AIGC Use Statement
  • Journal Subscription
  • Download Center
  • 中文版
Cite this article:
ZENG Lingshun,SHI Senpan,WANG Yile,TAN Lingzhi,TAN Xiyue,FU Lingping,ME Xiao.Study of Chidan Tuihuang Granules alleviating ANIT-induced cholestasis by inhibiting apoptosis signaling pathway[J].Journal Of Pharmaceutical Research,2025,44(12):1145-1152,1179[Click to copy]
【Print this page】      【Download PDF Full Text】   【View/Add Comment】  【Download reader】  【 Close 】
←Previous|Next→ Archive    Advanced Search
This article has been viewed: 2419times   Download 737次 QR Code for this article
Scan with your phone!
赤丹退黄颗粒通过抑制凋亡信号通路改善ANIT诱导胆汁淤积的作用规律
曾灵顺,石森蟠,王奕乐,谭玲芝,谭茜月,符玲萍,马骁
Font:Larger+|Default|Smaller-
(成都中医药大学药学院,中药种质资源创新与高效利用四川重点实验室,四川 成都 611137)
摘要:
目的 探讨赤丹退黄颗粒(CDTH)改善胆汁淤积性肝损伤的作用机制,揭示其调控胆汁淤积性疾病进程的生物学机制。方法 利用ANIT诱导的胆汁淤积模型评估赤丹退黄颗粒对胆汁淤积的治疗作用,通过网络药理学及分子对接技术CDTH治疗胆汁淤积的潜在核心靶点和通路。结果 动物实验证实CDTH显著降低肝功能指标,有效改善肝组织炎症浸润和脂肪变性;网络药理学分析显示CDTH治疗胆汁淤积显著富集于凋亡信号通路;分子对接分析证实,赤丹退黄颗粒活性成分与核心靶点(结合能均<-5.0 kcal·mol-1)具有稳定结合能力。结论 CDTH可有效改善ANIT诱导的胆汁淤积性肝损伤血清生化指标,抑制肝脏组织中胆汁淤积的凋亡信号通路蛋白的相关表达,从而发挥抗胆汁淤积性肝损伤的综合疗效。
关键词:  赤丹退黄颗粒  胆汁淤积  分子对接  网络药理学  细胞凋亡
DOI:10.13506/j.cnki.jpr.2025.12.001
基金项目:国家自然科学基金面上项目(No.82274187)
Publication Date:December 25, 2025
Study of Chidan Tuihuang Granules alleviating ANIT-induced cholestasis by inhibiting apoptosis signaling pathway
ZENG Lingshun,SHI Senpan,WANG Yile,TAN Lingzhi,TAN Xiyue,FU Lingping,ME Xiao
(School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu 611137,China)
Abstract:
Objective To explore the mechanisms by which Chidan Tuihuang Granules (CDTH) improve cholestatic liver injury and to reveal the biological mechanisms that regulate the progression of cholestasis. Methods Using an ANIT-induced cholestasis model, the therapeutic effects of CDTH on cholestasis were evaluated. Network pharmacology and molecular docking techniques were used to identify potential core targets and pathways for CDTH in treating cholestasis. Results Animal experiments confirmed that CDTH significantly reduced liver function indicators and effectively improved liver tissue inflammation and steatosis. Network pharmacology analysis showed that CDTH treatment of cholestasis was significantly enriched in apoptosis signaling pathways. Molecular docking analysis confirmed that the active components of Chidan Tuihuang Granules have a stable binding ability with core targets (binding energy <-5.0 kcal·mol-1). Conclusion CDTH can effectively improve serum biochemical indicators of ANIT-induced cholestasis, inhibit the expression of apoptosis signaling pathway protein in cholestatic of liver tissue, and thus exert a comprehensive therapeutic effect against cholestasis.
Key words:  Chidan Tuihuang Granules  Cholestasis  Molecular docking  Network pharmacology  Apoptosis
Today's Visits:527    Total Visits:2383269
Website copyright:Editorial Board of Journal of Pharmaceutical Research     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
Sponsored by:Shandong Institute for Food and Drug Control Shandong Pharmaceutical Association Address:No.2749 Xinluo Street,High-Tech Zone,Jinan,P.R.China Postcode:250101
Telephone Number:0531-81216586 Email :yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
Technical Support:Beijing Qinyun Technology Co., Ltd.